Etanercept helps restore normal growth in children with juvenile arthritis

November 03, 2010

Researchers from the Cincinnati Children's Hospital Medical Center observed a statistically significant increase in mean height, weight, and body mass index (BMI) percentiles in patients with juvenile idiopathic arthritis (JIA) who were treated with etanercept or etanercept plus methotrexate (MTX). JIA patients treated with MTX alone did not display an increase in growth percentiles. Results of the 3-year study are available online and in the November issue of Arthritis & Rheumatism, a journal published by Wiley-Blackwell on behalf of the American College of Rheumatology.

Juvenile idiopathic arthritis (JIA), one of the most common rheumatic diseases in children, causes significant pain and functional disability. According to a 2008 study by the National Arthritis Data Workgroup, there are close to 300,000 children in the U.S. with some form of juvenile arthritis. Prior studies show that JIA patients may experience impaired physical growth and development dependent upon the severity of chronic inflammation, longer duration of disease, and greater functional joint involvement.

"A realistic treatment goal for JIA patients should include therapy aimed at reducing inflammation in an effort to minimize disease-related disability and growth impairment," said lead author of the study Edward Giannini, DrPH, MSc. Dr. Giannini and colleagues conducted a 3-year, nonrandomized multi-center registry of 594 patients with polyarticular (90%) or systemic JIA who were treated with etanercept only, etanercept plus MTX, or MTX only.

Participants between the ages of 2 and 18 who enrolled in the registry were treated with etanercept twice weekly at a dose of 0.4 mg/kg or once weekly at a dose of 0.8 mg/kg. The height, weight, and BMI for each patient were recorded at baseline, years 1, 2, and 3, and compared with the U.S. Centers for Disease Control and Prevention standardized growth charts to obtain the percentiles.

The authors reported that the mean height in the etanercept group significantly increased by 4.8 percentile points by year 3. For those in the etanercept plus MTX group, a significant increase in mean height in years 1, 2, and 3 was also recorded--2.4, 3.3, and 5.6 percentile points, respectively. Similar significant increases in weight percentiles at years 1, 2 and 3, respectively, were observed in the etanercept-only group (7.4, 10.0, and 13.0) and in the etanercept plus MTX group (2.9, 6.9, and 8.4). BMI percentiles also increased significantly over the 3-year period, ranging from 9.6 to 13.8 percentile points in the etanercept-only group and from 2.1 to 5.2 percentile points in the etanercept plus MTX group.

"Studies have shown that growth retardation is associated with systemic inflammation and is a potentially permanent complication of JIA," explained Dr. Giannini. "Restoring normal growth development is a relevant goal of anti-inflammatory treatment in JIA patients and our study showed significant increases in height, weight, and BMI percentiles for those treated with etanercept alone or in combination with MTX." Significant changes in growth measures were not observed for patients receiving only MTX treatment.
Article: "Effects of Long-Term Etanercept Treatment on Growth in Children with Selected Categories of Juvenile Idiopathic Arthritis." Edward H. Giannini, Norman T. Ilowite, Daniel J. Lovell, Carol A. Wallace, C. Egla Rabinovich, Andreas Reiff, Gloria Higgins, Beth Gottlieb, for the Pediatric Rheumatology Collaborative Study Group, Yun Chon, Nan Zhang, and Scott W. Baumgartner. Arthritis & Rheumatism; Published Online: July 28, 2010 (DOI: 10.1002/art.27682); Print Issue Date: November 2010.

This study is published in the November issue of Arthritis & Rheumatism. Media wishing to receive a PDF of the article may contact

About the Journal

Arthritis & Rheumatism is an official journal of the American College of Rheumatology (ACR) and the Association of Rheumatology Health Professionals (ARHP), a division of the College, and covers all aspects of inflammatory disease. The American College of Rheumatology ( is the professional organization who share a dedication to healing, preventing disability, and curing the more than 100 types of arthritis and related disabling and sometimes fatal disorders of the joints, muscles, and bones. Members include practicing physicians, research scientists, nurses, physical and occupational therapists, psychologists, and social workers. For details, please visit

About Wiley-Blackwell

Wiley-Blackwell is the international scientific, technical, medical, and scholarly publishing business of John Wiley & Sons, with strengths in every major academic and professional field and partnerships with many of the world's leading societies. Wiley-Blackwell publishes nearly 1,500 peer-reviewed journals and 1,500+ new books annually in print and online, as well as databases, major reference works and laboratory protocols. For more information, please visit or our new online platform, Wiley Online Library (, one of the world's most extensive multidisciplinary collections of online resources, covering life, health, social and physical sciences, and humanities.

Media Advisory

ACR Annual Meeting Press Registration Now Open

Press registration is now open to journalists planning to attend the 2010 ACR/ARHP Annual Scientific Meeting in Atlanta. Held November 6-11 at the Georgia World Congress Center, the ACR/ARHP Annual Scientific Meeting is the premier meeting in rheumatology.

For more information, including to view the press conference schedule, visit Follow the meeting on twitter by using the official hashtag: #ACR2010.


Related Weight Articles from Brightsurf:

How much postmenopause weight gain can be blamed on weight-promoting medications?
Abdominal weight gain, which is common during the postmenopause period, is associated with an array of health problems, including diabetes and heart disease.

Commercial weight management groups could support women to manage their weight after giving birth
Women who were overweight at the start of their pregnancy would welcome support after they have given birth in the form of commercial weight management groups, University of Warwick-led research has found.

Rollercoaster weight changes can repeat with second pregnancy, especially among normal-weight women
Everyone knows that gaining excess weight during one pregnancy is bad, but clinicians rarely consider weight gains and losses from one pregnancy to the next -- especially in normal-weight women.

Early and ongoing experiences of weight stigma linked to self-directed weight shaming
In a new study published today in Obesity Science and Practice, researchers at Penn Medicine and the University of Connecticut Rudd Center for Food Policy and Obesity surveyed more than 18,000 adults enrolled in the commercial weight management program WW International, and found that participants who internalized weight bias the most tended to be younger, female, have a higher body mass index (BMI), and have an earlier onset of their weight struggle

Being teased about weight linked to more weight gain among children, NIH study suggests
Youth who said they were teased or ridiculed about their weight increased their body mass by 33 percent more each year, compared to a similar group who had not been teased, according to researchers at the National Institutes of Health.

Association between weight before pregnancy, weight gain during pregnancy and adverse outcomes for mother, infant
An analysis that combined the results of 25 studies including nearly 197,000 women suggests prepregnancy body mass index (BMI) of the mother was more strongly associated with risk of adverse maternal and infant outcomes than the amount of gestational weight gain.

Study: Faster weight loss no better than slow weight loss for health benefits
Losing weight slowly or quickly won't tip the scale in your favor when it comes to overall health, according to new research.

What your choice of clothing says about your weight
It's commonly said that you can tell a great deal about a person by the clothes they wear.

Stand up -- it could help you lose weight
You might want to read this on your feet. A new study published today in the European Journal of Preventive Cardiology found that standing instead of sitting for six hours a day could prevent weight gain and help people to actually lose weight.

Cash for weight loss
A new study, published in the journal Social Science and Medicine, has shown that selling rewards programmes to participants entering a weight loss programme is a low cost strategy to increase both the magnitude and duration of weight loss.

Read More: Weight News and Weight Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to